History

1950

Taro facility for pharmaceutical end products established in Israel

1961

Active pharmaceutical ingredients (API) for Taro products manufactured in Israel

1984

Creams and ointments factory in Canada acquired and operated

1988

Entered US market

2003

Branded product division established

2006

State-of-the-art manufacturing facilities launched at Taro Israel

2010

Taro acquired by Sun Pharmaceuticals

2012

Over $1 billion in gross sales (IMS 2012 sales)

2012

IPO on New York stock exchange.

2016

Taro is leading generic dermatological company in US.